trial

TDCS for Auditory Hallucinations in Schizophrenia

NCTId NCT01898299
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 89 (actual)
Sponsored by New York State Psychiatric Institute, Washington Heights Community Service
Primary completion 2018-07-14
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
89 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2013-05
Primary completion
2018-07-14
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Drugs
transcranial direct current stimulation (tDCS)

Sponsors

New York State Psychiatric Institute, Washington Heights Community ServiceLead Sponsor
Stanley Medical Research InstituteCollaborator

Investigators

1
Daniel C. Javitt, MD, PhDPrincipal Investigator

Sites

2 total
New York, United StatesOrangeburg, United States

Facts & assertions

4 sourced
Enrollment
89
Phase
NA
Primary Completion Date
2018-07-14
Status
COMPLETED
relationships
The graph out of here
drug
transcranial direct current stimulation (tDCS)
drug
lead_sponsor
New York State Psychiatric Institute, Washington Heights Community Service
company
collaborator
Stanley Medical Research Institute
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Daniel C. Javitt, MD, PhD
person